<DOC>
	<DOCNO>NCT00993070</DOCNO>
	<brief_summary>Painful diabetic neuropathy common cause neuropathic pain . 0.075 % topical capsaicin use treat pain , data low concentration . This efficacy safety 0.025 % topical capsaicin treatment painful diabetic polyneuropathy .</brief_summary>
	<brief_title>Efficacy Safety Study Topical Capsaicin Painful Diabetic Neuropathy</brief_title>
	<detailed_description>Patient randomize receive either 0.025 % topical capsaicin vehicle control ( placebo ) 8 week . After one week wash-out period , patient switch group 8 week . Outcome assess visual analog scale , neuropathic pain scale , SF-MPQ , SF-36 . Safety tolerability record .</detailed_description>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>History type 2 Diabetes mellitus Peripheral neuropathy Stabilized pain medication least one month No previous invasive intervention pain relief Local wound skin abnormality applicable area Allergic capsaicin Refuse participate give consent Has significant disease receive medication may worsen neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>capsaicin</keyword>
	<keyword>placebo</keyword>
	<keyword>trial</keyword>
	<keyword>diabetic polyneuropathy</keyword>
	<keyword>neuropathic pain</keyword>
</DOC>